Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

Turkolmez, KADİR; Beduk, Y; Baltaci, S; Gogus, ÇAĞATAY; Gogus, O

doi:10.1016/s0302-2838(03)00385-3

Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

Turkolmez K., Beduk Y., Baltaci S., Gogus Ç. M., Gogus O.

European urology, cilt.44, sa.6, ss.682-6, 2003 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 6
Basım Tarihi: 2003
Doi Numarası: 10.1016/s0302-2838(03)00385-3
Dergi Adı: European urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.682-6
Anahtar Kelimeler: gemcitabine, vinorelbine, bladder tumor, chemotherapy, TRANSITIONAL-CELL-CARCINOMA, PHASE-II TRIAL, METASTATIC UROTHELIAL CANCER, COOPERATIVE-ONCOLOGY-GROUP, URINARY-TRACT, BREAST-CANCER, METHOTREXATE, VINBLASTINE, COMBINATION, IFOSFAMIDE
Ankara Üniversitesi Adresli: Evet

Özet

Objective: To evaluate the efficacy and toxicity of gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are unsuitable for or who have failed cisplatin-containing chemotherapy.